[Hepatogenic diabetes--the current concepts of its pathophysiology and therapy].
Siegel
E G
EG
I. Medizinische Klinik, Allgemeine Innere Medizin, Christian-Albrechts-Universität zu Kiel.
Gallwitz
B
B
Schmidt
W E
WE
Fölsch
U R
UR
D003920:Diabetes Mellitus / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology; D005768:Gastrointestinal Hormones / Q000627:therapeutic use; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D004763:Glucagon-Like Peptides; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D008099:Liver / Q000378:metabolism; D008107:Liver Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D010446:Peptide Fragments / Q000627:therapeutic use; D011972:Receptor, Insulin / Q000378:metabolism
D005768:Gastrointestinal Hormones; D007004:Hypoglycemic Agents; D010446:Peptide Fragments; C055453:glucagon-like peptide 1 (7-36)amide; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D011972:Receptor, Insulin; D005947:Glucose